Skip to content

Disc Medicine IRON Common Stock

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1K0.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$76K+2.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$1.03M+2.1%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$9K0.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's common stock?
Disc Medicine (IRON) reported common stock of $4K in Q1 2026.
How has Disc Medicine's common stock changed year-over-year?
Disc Medicine's common stock increased by 33.3% year-over-year, from $3K to $4K.
What is the long-term trend for Disc Medicine's common stock?
Over 5 years (2020 to 2025), Disc Medicine's common stock has grown at a 14.9% compound annual growth rate (CAGR), from $2K to $4K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).